Crane Biosciences
ActiveRed blood cell-derived nanoparticle platform for brain mRNA delivery.
What it does
Crane Biosciences engineers red blood cell–based nanoparticles to transport nucleic acid therapeutics across the blood-brain barrier—supporting precise, minimally invasive delivery for neurological diseases.